sharetrader
Page 915 of 2125 FirstFirst ... 415815865905911912913914915916917918919925965101514151915 ... LastLast
Results 9,141 to 9,150 of 21246
  1. #9141
    Senior Member
    Join Date
    Apr 2013
    Location
    Pourquoi?
    Posts
    873

    Default

    Short termers are loving it...

  2. #9142
    Member
    Join Date
    Nov 2013
    Posts
    470

    Default

    Whilst looking for something else, I stumbled upon some information about the cxbladder test which were of interest to me:

    http://www.healthscopepathology.com....ogy/cxbladder/
    There's a link to a brochure and clinical validation overview on the left.

  3. #9143
    Banned
    Join Date
    Sep 2012
    Location
    Christchurch
    Posts
    1,985

    Default

    Quote Originally Posted by Carpenterjoe View Post
    I recall a slide from a peb presentation, it showed the test being used multiple times when first diagnosed (maybe up to eight times.)

    8 x 2000 =16000
    16000 tests to show off the cx product at a cost of 1-2mill????

    Again not big dollars, and the opportunity is endless. But it will add to the expenses and its useful to have an understanding of these costs.
    From the announcement;

    “The Kaiser Permanente User Program research project is planned to recruit approximately 2000 patients presenting with microscopic and macroscopic hematuria (blood in the urine), from the 3.7 million members of Kaiser Permanente Southern California.”

    No, definitely not millions of dollars, just a couple of hundred thousand, the “2,000 patients” are not ‘cancer patients’, they are ‘haematuria patients’, thus requiring preliminary screening rather than work-up tests.

    It's possible but unlikely that most would get tested twice within that six month duration, perhaps some of those tested close to the commencement of the programme may though, depends what’s been agreed.

  4. #9144
    Member
    Join Date
    Oct 2011
    Posts
    307

    Default

    Quote Originally Posted by MAC View Post
    From the announcement;

    “The Kaiser Permanente User Program research project is planned to recruit approximately 2000 patients presenting with microscopic and macroscopic hematuria (blood in the urine), from the 3.7 million members of Kaiser Permanente Southern California.”

    No, definitely not millions of dollars, just a couple of hundred thousand, the “2,000 patients” are not ‘cancer patients’, they are ‘haematuria patients’, thus requiring preliminary screening rather than work-up tests.

    It's possible but unlikely that most would get tested twice within that six month duration, perhaps some of those tested close to the commencement of the programme may though, depends what’s been agreed.
    It's also not clear whether KP will be paying for the tests or whether they will be freebies. I'm picking that they will be paying.

  5. #9145
    Banned
    Join Date
    Sep 2012
    Location
    Christchurch
    Posts
    1,985

    Default

    Quote Originally Posted by Poet View Post
    It's also not clear whether KP will be paying for the tests or whether they will be freebies. I'm picking that they will be paying.
    Pacific Edge described it as being similar to the Mid Central Heath user programme, so we should also expect PEDusa to similarly pick up the tab.

    Both user programmes are more a commercial evaluation than a clinical evaluation.

    “Cxbladder is currently being evaluated in New Zealand for a similar clinical value proposition by Mid-Central District Health Board in Palmerston North. The commercial evaluation by Mid-Central DHB is to establish the levels of patient benefits and savings that can be achieved from the use of Cxbladder in a similar clinical setting to Kaiser Permanente by ruling out patients referred with micro-haematuria who do not have bladder cancer.”

  6. #9146
    Member
    Join Date
    Mar 2014
    Posts
    415

    Default

    Quote Originally Posted by snapiti View Post
    I bet you that's not what the clinicians think
    Unfortunately snapiti, I think your right, Nz Clinicians are worried more about how much CX bladder costs and how it won't fit their budgets.
    But in the states, if a urologists mistake allows a person to die, they and their practice could be liable for massive lawsuits. Especially when you have a reliable product like Cxbladder that could have picked up what they missed.
    Americans don't like to be sued, hence the cx bladder market. Kiwi urologists don't have that pressure and unfortunately the condition of some of the medical boards in new Zealand is simple distributing.

    This opportunity is much bigger than anything NZ could offer.

  7. #9147
    Speedy Az winner69's Avatar
    Join Date
    Jun 2001
    Location
    , , .
    Posts
    37,876

    Default

    Quote Originally Posted by winner69 View Post
    Hope today sees another push towards 90 cents ....and then onto a$1.00
    Just having a breather at the end of week

    Up 12 cents since fiasco of the ASM and up 9 cents this week so all positive

    More impetus in this rise from below 70 cents which suggests a lot more support now

    That 110 mark on the chart looks a good target - was looking at 100 but I think I'll aim for the 110, by end of September

    Next week another 9 cents will be fine

  8. #9148
    Member
    Join Date
    Mar 2014
    Posts
    415

    Default

    Quote Originally Posted by snapiti View Post
    All very true.... unfortunately the US law system in not favorable to get healthcare specialist to use a product that is not published in clinical pathways.
    STC always brought up the fact that PEB needs to be included in the written clinical pathways before a large adoption rate can occur.
    Once cx bladder is included in clinical pathways it will give the urologist some assurance that their butts are covered.
    This will be a very long process
    I have no idea of the American law system. But I know Americans, and if somebody dies when it was easily preventable (like pissing in a cup). Then change will be forced, all it takes is this user programme to highlight a few American urologists mistakes and they will conform, Completely agree, positive sales figures are a long way away. But I see this company being a lot bigger than one product.

  9. #9149
    Guru
    Join Date
    Feb 2010
    Posts
    3,809

    Default

    Lets just all keep our feet on the ground--we dont need to get into ''hype'' territory again.
    Slow steady growth will do just fine.

  10. #9150
    Banned
    Join Date
    Sep 2012
    Location
    Christchurch
    Posts
    1,985

    Default

    Seems that it’s all going pretty much to plan as it was all laid out.

    Four network providers signed up thus far, the first HMO negotiation concluding with KP and an associated user programme ready to go, preliminary negotiations with Medicare made whom have been accruing revenues for Pacific Edge for a year or so now.

    So, they are ahead with signing up network providers, about roughly on track with KP or within a few months at least, and may probably be a little ahead with Medicare and Medicaid negotiations.

    Pacific Edge are doing a damn fine job IMHO.

    From the October 2013 capital raising:

    Pacific Edge is targeting large, integrated healthcare providers (such as Kaiser Permanente and Intermountain) where the insurance, hospital and medical group functions are fully integrated with a focus on best, most cost effective clinical outcome for members.

    • Kaiser Permanente, for example, has 8.9 million members2
    • These integrated healthcare providers are targeted to be strategic partners for Pacific Edge – discussions have commenced between Pacific Edge and various integrated healthcare providers, however it is anticipated that negotiations could take 12 months

    Building a relationship with the CMS is a key target for Pacific Edge (CMS is the US federal agency which administers Medicare and Medicaid and will reimburse Pacific Edge for all Medicare / Medicaid patients who utilise Cxbladder)

    • Pacific Edge anticipates continuing and concluding negotiations in earnest with Medicare and Medicaid in 2014. Pacific Edge has already conducted preliminary discussions with these entities.
    • Approximately 115 million U.S. citizens are covered by Medicare and Medicaid

Tags for this Thread

Bookmarks

Posting Permissions

  • You may not post new threads
  • You may not post replies
  • You may not post attachments
  • You may not edit your posts
  •